FGD3 Boosts Breast Cancer Treatment – Chemotherapy & Immunotherapy

Here’s a breakdown of the information provided in the text:

Research Article:

* ⁣ Title: FGD3 mediates⁢ lytic cell death, ⁣enhancing efficacy and immunogenicity of chemotherapy agents in ​breast cancer
* Journal: Journal of Experimental & Clinical Cancer Research

* ‍ Publication Year: 2025
* ‍ DOI: 10.1186/s13046-025-03559-5
* key Finding: The cellular protein FGD3 enhances the effectiveness of both chemotherapy and immunotherapy in treating breast‌ cancer.

Source:

* Provided by: University of Illinois at Urbana-Champaign
* University Website: http://illinois.edu/

Citation (for print):

* Title: Cellular protein FGD3 boosts breast cancer chemotherapy and ⁣immunotherapy, study finds
* Date: November ‌12, 2025
* ‌⁢ Retrieved Date: november 12, 2025⁢ (likely the date of publication/access)